Stem Cell Co. Says Rival Infringed Blood Product Patents

Law360, New York (October 30, 2012, 5:17 PM EDT) -- Cell therapy equipment company Harvest Technologies Corp. hit rival ThermoGenesis Corp. with a patent infringement lawsuit last week, claiming a distributor leaked its patented blood separator technology to the competitor.

Harvest says ThermoGenesis’ Res-Q products are a ripoff of its own SmartPrep products that are protected by two U.S. patents, according to complaint filed on Oct. 24 in Delaware. Both equipment systems are used in the process of creating and administering stem cell-based recovery treatments.

The suit says that SpineSmith LP — a former Harvest distributor that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.